“The Trump administration must confront foreign governments directly to end pharmaceutical … More
This morning, the America First Policy Institute released an issue brief highlighting a genuine problem—the rest of the world free-rides on American pharmaceutical innovation. American consumers bear most of the global costs associated with drug research and development and so subsidize lower prices abroad.
President Trump is already working…
Continue Reading
News Source: www.forbes.com
Leave a Reply